目的:本研究之目的為研製含硼碘化油(B-lipiodol),探討人類肝癌細胞(HepG2 Cells)對B-lipiodol之積聚效果及中子照射後之細胞毒性。 材料與方法:培養中之人類肝癌細胞測試其對B-lipiodol之攝入及積聚。以光學顯微鏡檢視B-lipiodol與肝癌細胞間之交互作用。以感應偶合電漿原子發射光譜分析儀分析硼含量。經B-lipiodol處理之肝癌細胞於清華水池式反應器中接受中子照射。 結果:血清中穩定性測試,結果顯示硼可穩定存於B-lipiodol中。肝癌細胞可大量攝入、積聚B-lipiodol。在我們的測試條件下,中子捕獲對B-lipiodol處理之肝癌細胞具有極高之細胞毒性、劑量反應曲綫相當陡。 結論:受測人類肝癌細胞會攝入B-lipiodol,且有足够量之硼會滯留於細胞中以供中子捕獲反應用。B-lipiodol應用於人類肝癌細胞之硼中子捕獲殺傷上是一具高細胞毒性藥物。
Objective: The objective of this study was designed to preparation of the boron containing lipiodol (B-lipiodol) for boron neutron capture therapy, and evaluation of the cytotoxicity of B-lipiodol on hepatoma cells after neutron irradiation. Materials and Methods: HepG2 cell culture was used to examine of the uptake and retention of B-lipiodol. Light microscopes were used for examination of the interaction and retention of 8-lipiodol droplets in the individual cell. Boron concentration was determined by ICPASS analysis. THOR was used for irradiation of the B-lipiodol treated HepG2 cells. Results: Stability test showed that boron was stably retained in lipiodol contrast medium. HepG2 cells appeared proficiently at internalization and retention of B-lipiodol. Under our tested condition, boron neutron capture was highly cytotoxic in B-lipiodol treated HepG2 cells. There was a steep dose response relationship. Conclusion: Hepatoma cells are capable of active uptake of B-lipiodol and enough amount of boron was retention inside the cells for neutron capture reaction. B-lipiodol is a highly cytotoxic and effective drug for the neutron-capture killing of FIepG2 cells.